David M. Barrett

2 ta ish

Kite (United States)

1. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

   Stephan A. Grupp, Michael Kalos, David M. Barrett +10

   MaqolaOAOchiq kirish20133 iqtibos

   ABIABI:AkademIndex/2026.other.082765

2. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

   Stephen Bagley, Meghan Logun, Joseph A. Fraietta +30

   MaqolaOAOchiq kirish20242 iqtibos

   ABIABI:AkademIndex/2026.other.102963